James T. Gunton is Director & 10% at Cytosorbents Corp (CTSO). They have made 2 open-market trades across 1 company since 2014, most recently 2015-04-08.
CIK 0001443723
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CTSO | 55,000 | $223K |
Shares reported on the most recent Form 4, priced at the 2015-04-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CTSO | SELL · 10b5-1 | 2014-10-14 | 2014-10-16 | $0.24 | $35K | -22.2% | +3.3% | +3.3% |
| CTSO | SELL · 10b5-1 | 2014-10-09 | 2014-10-14 | $0.24 | $298K | -22.2% | +3.3% | +3.3% |
| CTSO | SELL · 10b5-1 | 2014-09-15 | 2014-09-22 | $0.24 | $4K | -22.2% | +3.3% | +3.3% |
| CTSO | SELL · 10b5-1 | 2014-09-11 | 2014-09-15 | $0.24 | $7K | -22.2% | +3.3% | +3.3% |
| CTSO | SELL | 2014-08-28 | 2014-09-02 | $0.24 | $51K | -22.2% | +3.3% | +3.3% |
| CTSO | SELL | 2014-08-26 | 2014-08-28 | $0.24 | $326K | -22.2% | +3.3% | +3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.